Tracking Real-World Outcomes
The TVT Registry™ is a benchmarking tool developed to track patient safety and real-world outcomes related to the transcatheter aortic valve replacement (TAVR) procedure. Created by The Society of Thoracic Surgeons (STS) and the American College of Cardiology (ACC), the TVT Registry is designed to monitor the safety and efficacy of this new procedure for the treatment of aortic stenosis.
Employing a first-of-its-kind transcatheter heart valve technology, TAVR provides a new treatment option for patients who are considered to be inoperable for conventional aortic valve replacement surgery.
Through the capture and reporting of patient demographics, procedure details, and facility and physician information, the TVT Registry provides a data repository capable of delivering insight into clinical practice patterns and patient outcomes.
Additionally, the TVT Registry has been approved by the Centers for Medicare and Medicaid Services (CMS) to meet the registry requirement outlined in the Medicare National Coverage Decision on TAVR.
Read More About the CMS National Coverage Determination for TAVR
Visit the Official CMS Page for Transcatheter Aortic Valve Replacement (TAVR)
Watch an Informational Video About the TVT Registry
For Participating Hospitals, the TVT Registry Offers:
Quarterly reports containing practice patterns, demographics and outcomes of procedures that compare an institution’s performance with that of the national experience
Standardized, evidence-based data elements and definitions
A web-based data collection tool
A wide range of other quality improvement tools to advance quality improvement initiatives
Fulfillment of the CMS registry participation requirement for TAVR procedures
Providing an Invaluable Data Source
Backed by the registry expertise of the ACC’s NCDR® and the STS National Database, the TVT Registry serves as the main repository for clinical data related to TAVR and is positioned to incorporate future catheter-based procedures.
A powerful data source, the registry allows the cardiovascular profession to monitor important safety information, detect infrequent complications and build the robust clinical research infrastructure necessary to advance the science surrounding the TAVR procedure. In this capacity, it will serve as a tool for conducting research in areas of comparative effectiveness, cost effectiveness and appropriate use criteria.
Analysis of these data will allow the cardiovascular profession and medical community to understand how this new technology will be deployed throughout the U.S., and what impact it will have on patient outcomes as it becomes more prevalent. Data from the TVT Registry will assist the medical device industry and the FDA in surveillance of the quality, safety and efficacy of new medical devices.
View a list of current TVT Registry participants